SCHEMBL4603583

SCHEMBL4603583

CS(=O)(=O)c1nsc(-c2ccccc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.50
ADORA2A P29274 1/20 0.50
ADORA2B P29275 1/20 0.50
ADORA1 P30542 1/20 0.50
RAB9A P51151 5/20 0.45
HTT P42858 3/20 0.45
TP53 P04637 3/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 2/20 0.45
MAPK1 P28482 2/20 0.45
MEN1 O00255 1/20 0.45
S1PR4 O95977 1/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
S1PR1 P21453 1/20 0.45
SDHB P21912 1/20 0.45
STAT3 P40763 1/20 0.45
STAT1 P42224 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5294276 0.84 ALDH1A1 (0.47) RAB9AHTTHPGDMEN1LMNA
SCHEMBL4606885 0.82 CHRNA7 (0.48) ADORA3PTGS2SMN1; SMN2KDM4E
SCHEMBL4605302 0.81 KMT2A (0.44) ADORA3RAB9AHTTTP53HPGD
SCHEMBL4606363 0.79 PTGS2 (0.42) HTTHPGDLMNASDHBSTAT3
SCHEMBL4606713 0.77 PTGS2 (0.46) HTTTP53HPGDHSD17B10PTGS2
SCHEMBL1271340 0.75 ADORA3 (0.50) ADORA3ADORA2AADORA2BADORA1RAB9A
SCHEMBL6849437 0.71 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1RAB9A
SCHEMBL8101030 0.71 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1RAB9A
SCHEMBL7695561 0.69 ADORA3 (0.52) ADORA3ADORA2AADORA2BADORA1RAB9A
SCHEMBL2212694 0.69 CYP19A1 (0.67) ADORA3ADORA2AADORA2BADORA1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1574505-B1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2008-07-16 EP disclosed
US-7361675-B2 1,2,4-thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-04-22 US disclosed
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-27 US disclosed
EP-1574505-A1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof CBR3, CBR1, NOX3 ADORA3 497/4885ADORA2A 2646/4885ADORA2B 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.